These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
588 related articles for article (PubMed ID: 16919342)
1. Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure. Corell P; Gustafsson F; Kistorp C; Madsen LH; Schou M; Hildebrandt P Int J Cardiol; 2007 May; 117(3):395-402. PubMed ID: 16919342 [TBL] [Abstract][Full Text] [Related]
2. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Morello A; Lloyd-Jones DM; Chae CU; van Kimmenade RR; Chen AC; Baggish AL; O'Donoghue M; Lee-Lewandrowski E; Januzzi JL Am Heart J; 2007 Jan; 153(1):90-7. PubMed ID: 17174644 [TBL] [Abstract][Full Text] [Related]
3. The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. Shelton RJ; Clark AL; Goode K; Rigby AS; Cleland JG Eur Heart J; 2006 Oct; 27(19):2353-61. PubMed ID: 16952921 [TBL] [Abstract][Full Text] [Related]
4. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
5. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP. Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Van Veldhuisen DJ Europace; 2006 Jul; 8(7):482-7. PubMed ID: 16798760 [TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction. Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293 [TBL] [Abstract][Full Text] [Related]
7. [Changes in NT-proBNP levels in patients with atrial fibrillation related to heart failure]. Pokorná V; Jurkovicová O; Kaluzay J; Stecová A; Pont'uch P Vnitr Lek; 2010 Aug; 56(8):788-94. PubMed ID: 20845610 [TBL] [Abstract][Full Text] [Related]
8. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea. Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868 [TBL] [Abstract][Full Text] [Related]
9. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure. Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415 [TBL] [Abstract][Full Text] [Related]
10. Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation. Buob A; Jung J; Siaplaouras S; Neuberger HR; Mewis C Pacing Clin Electrophysiol; 2006 Jun; 29(6):559-63. PubMed ID: 16784419 [TBL] [Abstract][Full Text] [Related]
11. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases. Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction. Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998 [TBL] [Abstract][Full Text] [Related]
13. Comparative value of BNP and NT-proBNP in diagnosis of heart failure. Fonseca C; Sarmento PM; Minez A; Gonçalves E; Covas R; Dias AR; Pina MJ; Ceia F Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324 [TBL] [Abstract][Full Text] [Related]
14. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center. Amir O; Paz H; Ammar R; Yaniv N; Schliamser JE; Lewis BS Isr Med Assoc J; 2008 Feb; 10(2):109-12. PubMed ID: 18432021 [TBL] [Abstract][Full Text] [Related]
16. Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic Peptide prohormone levels in patients with persistent atrial fibrillation. Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Goudis CA; Maliaraki NE; Saloustros IG; Milathianaki ME; Chlouverakis GI; Vardas PE Am J Cardiol; 2010 Jan; 105(1):90-4. PubMed ID: 20102897 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients. Pascual-Figal DA; Domingo M; Casas T; Gich I; Ordoñez-Llanos J; Martínez P; Cinca J; Valdés M; Januzzi JL; Bayes-Genis A Eur Heart J; 2008 Apr; 29(8):1011-8. PubMed ID: 18263871 [TBL] [Abstract][Full Text] [Related]
18. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease. Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921 [TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure. Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846 [TBL] [Abstract][Full Text] [Related]
20. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]